SCHEMBL13868641

SCHEMBL13868641

COc1ccc(-c2cc3c(O)cc4c(c3cc2-c2ccc(OC)cc2)-c2ccccc2C42CC(C)(C)CC(C)(C)C2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
ABL1 P00519 2/20 0.37
ABCB1 P08183 2/20 0.37
BCR P11274 2/20 0.37
BACE1 P56817 3/20 0.37
PDK2 Q15119 4/20 0.37
MEN1 O00255 3/20 0.34
RAB9A P51151 3/20 0.34
KMT2A Q03164 3/20 0.34
NPC1 O15118 2/20 0.34
KDM4E B2RXH2 1/20 0.34
LMNA P02545 1/20 0.34
ALOX15 P16050 1/20 0.34
ALOX12 P18054 1/20 0.34
NFKB1 P19838 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10292865 0.94 RAB9A (0.37) HDAC4HDAC2HDAC8ABL1ABCB1
SCHEMBL15449591 0.94 HDAC4 (0.37) HDAC4HDAC2HDAC8ABL1ABCB1
SCHEMBL13868672 0.94 HDAC4 (0.37) HDAC4HDAC2HDAC8ABL1ABCB1
SCHEMBL13868637 0.94 RAB9A (0.37) HDAC4HDAC2HDAC8ABL1ABCB1
SCHEMBL13881220 0.93 RAB9A (0.36) HDAC4HDAC2HDAC8ABL1ABCB1
SCHEMBL10262342 0.92 HDAC4 (0.36) HDAC4HDAC2HDAC8ABL1ABCB1
SCHEMBL15452320 0.91 HDAC4 (0.35) HDAC4HDAC2HDAC8ABL1ABCB1
SCHEMBL13868732 0.91 BACE1 (0.35) HDAC4HDAC2HDAC8ABL1ABCB1
SCHEMBL13868651 0.90 PDK2 (0.41) HDAC4HDAC2HDAC8ABL1ABCB1
SCHEMBL13868693 0.89 RAB9A (0.36) HDAC4HDAC2HDAC8ABL1ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7521004-B2 Chromene compound TOKUYAMA CORPORATION (JP) 2009-04-21 US disclosed
US-7521004-B2 Chromene compound TOKUYAMA CORPORATION (JP) 2009-04-21 US disclosed
EP-1674460-B1 CHROMENE COMPOUND TOKUYAMA CORP (JP) 2009-01-21 EP disclosed
US-20070215844-A1 Chromene Compound TOKUYAMA CORPORATION (JP) 2007-09-20 US disclosed
US-20070215844-A1 Chromene Compound TOKUYAMA CORPORATION (JP) 2007-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070215844-A1 Chromene Compound CRY2, TYR, CRY1 HDAC4 2860/4885HDAC2 879/4885HDAC8 2304/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.